EDITORIAL (Thematic Issue: New Targets of Medical Treatment in Psychiatric Disorders)
Journal:
Current Neuropharmacology
Volume:
13
Page:
736-738
Author(s):
Kunio Yui
The Role of Topiramate in the Management of Cocaine Addiction: a Possible Therapeutic Option
Journal:
Current Neuropharmacology
Volume:
13
Page:
815-818
Author(s):
Antonio Siniscalchi, Antonello Bonci, Nicola Biagio Mercuri, Domenico Pirritano, Aida Squillace, Giovambattista De Sarro and Luca Gallelli
Functional Biomarkers: an Approach to Bridge Pharmacokinetics and Pharmacodynamics in Pediatric Clinical Trials
Journal:
Current Pharmaceutical Design
Volume:
21
Page:
5636-5642
Author(s):
Gregory L. Kearns and Michael Artman
Nanoparticles, Neurotoxicity and Neurodegenerative Diseases
Journal:
Current Drug Metabolism
Volume:
16
Page:
676-684
Author(s):
Gohar Mushtaq, Jalaluddin A. Khan, Ebenezer Joseph and Mohammad A. Kamal
The Effects of Creatine Supplementation and Physical Exercise on Traumatic Brain Injury
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
16
Page:
29-39
Author(s):
Luiz Fernando Freire Royes and Gustavo Cassol
Multi-Target Strategy and Experimental Studies of Traditional Chinese Medicine for Alzheimer’s Disease Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
16
Page:
537-548
Author(s):
Lin Li, Lan Zhang and Cui-cui Yang
Cognitive Improvement by Photic Stimulation in a Mouse Model of Alzheimer’s Disease
Journal:
Current Alzheimer Research
Volume:
12
Page:
860-869
Author(s):
Yu Zhang, Furong Wang, Xianwen Luo, Li Wang, Peng Sun, Min Wang, Yongsheng Jiang, Jingyu Zou, Osamu Uchiumi, Ryo Yamamoto, Tokio Sugai, Kenji Yamamoto and Nobuo Kato
The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
Journal:
Current Neuropharmacology
Volume:
13
Page:
681-691
Author(s):
Jennifer E. Thomas, Joshua Caballero and Catherine A. Harrington
Myalgic Encephalomyelitis: Symptoms and Biomarkers
Journal:
Current Neuropharmacology
Volume:
13
Page:
701-734
Author(s):
Leonard A. Jason, Marcie L. Zinn and Mark A. Zinn
Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 Alpha: An Emerging Target for Neuroprotection in Parkinson’s Disease
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
14
Page:
1024-1030
Author(s):
Nihar Ranjan Das and Shyam Sunder Sharma